SCHEMBL30482116

SCHEMBL30482116

CON(C)C(=O)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.49
MLYCD O95822 1/20 0.48
CFTR P13569 1/20 0.46
MRGPRX4 Q96LA9 5/20 0.43
PDE2A O00408 2/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 3/20 0.41
MAPT P10636 1/20 0.41
CES2 O00748 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2D6 P10635 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25377086 0.96 PDK2 (0.47) PDK2MLYCDCFTRMRGPRX4PDE2A
SCHEMBL25377082 0.93 PDK2 (0.45) PDK2MLYCDCFTRMRGPRX4PDE2A
SCHEMBL6714250 0.84 GAA (0.56) PDK2MLYCDCFTRPDE2ACYP11B1
SCHEMBL4208255 0.84 CFTR (0.50) PDK2MLYCDCFTRCYP11B1CYP11B2
SCHEMBL30214866 0.82 KDM4E (0.48) MLYCDCFTRGAAKDM4ECES2
SCHEMBL954114 0.82 CFTR (0.64) MLYCDCFTRCYP11B1CYP11B2GAA
SCHEMBL20247223 0.80 NPC1 (0.49) PDK2ALDH1A1HPGD
SCHEMBL8579430 0.80 MLYCD (0.46) MLYCDCFTRCYP11B1CYP11B2GAA
SCHEMBL2714908 0.80 CYP2C9 (0.46) KDM4EMAPTALDH1A1CYP2C19SMN1; SMN2
SCHEMBL1008380 0.80 CYP3A4 (0.54) KDM4EMAPTALDH1A1CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469438-A1 COMPOUNDS AND METHODS OF USE Tango Therapeutics, Inc. (US) 2024-12-04 EP disclosed
WO-2023146987-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed